Skip to main content
Premium Trial:

Request an Annual Quote

Get Personal

With its purchase of SeqWright for an undisclosed sum, GE is investing more in personalized medicine, The Wall Street Journal's Health Blog says. SeqWright is a contract genomic research organization that offers sequencing services among others, and GE says the company will supplement its 2009 purchase of Clarient, a cancer diagnostics company, for $580 million. Pharmaceutical companies are increasingly looking for targeted therapies, the Journal says, adding that clinicians then will have to be able determine patients' genetic profiles to match to the best therapies. "That's where GE hopes to come in, by developing technologies to better identify the genetic profile of cancers and other illnesses," the Journal notes.

"Combining the expertise and capabilities of the two companies will enable GE Healthcare to offer a substantially wider range of services to the biopharmaceutical, diagnostic and research industries and eventually to patients and health care providers," say GE Healthcare president and CEO Pascale Witz in a statement.

Our sister publication GenomeWeb Daily News has more on the deal here.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.